(S)-4-(1-Ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine

CAS : 1415565-02-4

Ref. 3D-QGC56502

Informations sur le produit

• Nom: (S)-4-(1-Ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine
• Marque: Biosynth
• Description: (S)-4-(1-Ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine (NXD 853) is an orally bioavailable small molecule that has been shown to be effective in treating liver damage in animals. It is a selective inhibitor of the RhoA pathway and has been shown to normalize serum transaminase levels in patients with chronic hepatitis B virus infection. In addition, it has been shown to reduce liver injury in rats following orthotopic liver transplantation. NXD 853 also reduces graft rejection rates after liver transplantation. The drug is currently being investigated for its ability to treat acute hepatic failure and other forms of severe liver disease.

Propriétés chimiques

• Masse moléculaire: 343.38 g/mol
• Formule: C₁₆H₂₁N₇O₂
• Degré de pureté: Min. 95%